H ypertrophic obstructive cardiomyopathy (HOCM) is a common genetic cardiovascular disease that can lead to significant morbidity and mortality. [1] [2] [3] Patients with HOCM often present with symptoms of dyspnea, angina, syncope, and heart failure, which can be refractory to medical therapy. 1, 4, 5 An alternative approach is alcohol septal ablation (ASA). This minimally invasive treatment has gradually gained acceptance over the past decade.
Predictive Value of Septal Thickness in ASA Procedure
in imaging, in particular cardiovascular magnetic resonance imaging (CMR), may help identify nonresponders and refine personalized treatment. 10, 11 In this study, we investigated the prognostic value of CMR and echocardiography in predicting post-ASA outcomes.
Methods

Study Population
Between January 2006 and December 2013, 104 patients were referred for ASA to our center. The diagnoses of HOCM were obtained by means of 2-dimensional (2D) echocardiography and CMR in patients with interventricular septal thicknesses ≥1.5 cm or ≥1.3 cm in adult relatives of HCM patients who had no other causes attributed to their LV hypertrophy. 2, 7 The selection criteria for ASA were as follows 12 : (1) the persistence of symptoms despite being administered the maximum tolerated dosage of medication; (2) LVOT gradient ≥50 mm Hg at rest or provoked (Valsalva maneuver); (3) accessible septal branches, typically of the left anterior descending coronary artery; (4) the absence of a significant intrinsic abnormality of the mitral valve and other conditions for which cardiac surgery was indicated. Two patients were excluded because of the first septal artery supplying both the proximal and the mid-interventricular septum (n=1), and an anomalous left anterior descending artery present (n=1). The remaining 102 were included as a retrospective cohort analysis, divided into 2 groups and analyzed based on the echocardiography results of LVOT gradient after ASA. The study was approved by an institutional review committee of Fuwai Hospital, National Center for Cardiovascular Diseases, China.
ASA Procedure
All 102 patients underwent ASA with a standard Judkins technique: A 6F pacemaker lead was placed in the right ventricle, a 6F pigtail catheter was positioned into the LV, and a 6F Judkins guiding catheter was positioned in the ascending aorta. Thus, the LVOT pressure gradient was continuously monitored throughout the procedure. After initial angiography for localizing the origin of the septal perforating arteries, a 1.5-to 2.5×10-mm balloon catheter was introduced over a 0.014-inch guidewire into septal branch perforator artery and inflated. X-ray contrast (Ultravist 370; Bayer Healthcare Pharmaceuticals, Berlin, Germany) was then injected through the balloon catheter shaft during simultaneous registration of transthoracic 2D echocardiography to determine the part of the myocardium supplied by the targeted septal artery. If balloon placement was correct, 1 to 3 mL of ethanol was slowly (1 mL/min) injected. Ten minutes after ethanol injection, the balloon was deflated and coronary angiography was repeated. A successful procedure was defined as a reduction in the LVOT pressure gradient ≥50% of baseline. If the results were not satisfactory, the whole procedure was repeated in another septal branch. All patients were monitored in the intensive or coronary care unit for 24 to 48 hours. The plasma creatine phosphokinase, creatine kinase-MB, and lactate dehydrogenase fraction levels were examined before ASA and every 6 hours after the procedure for a 36-hour period.
13
Echocardiography
All subjects underwent echocardiographic evaluation using an iE33 echocardiographic system (Philips Medical Systems, Best, The Netherlands) that was equipped with an S5-1transducer (frequency transmitted, 1.7 MHz; frequency received, 3.4 MHz) before and 6 months after the ASA procedure. One-lead ECG was recorded continuously. Echocardiographic measurements were performed following American Society of Echocardiography Guidelines. [14] [15] [16] Briefly, basal septal and posterior wall thicknesses were measured at enddiastole from basal short-axis and long-axis 2D echocardiography from the leading endocardial edge to leading epicardial edge, using the echocardiographic window that best identified the endocardial and epicardial borders. The LVOT gradient was measured with color-guided continuous-wave Doppler in the apical 3-chamber view. 13 We performed Valsalva maneuver for those with LVOT gradient <60 mm Hg at rest before ASA procedure. At 6-month follow-up, we divided patients into 2 groups: reduction in LVOT gradient ≥50% of baseline as ASA responding group and reduction in LVOT gradient <50% as ASA nonresponding group.
CMR Protocol
CMR examinations were performed using a 1.5 Tesla MR scanner (Magneton Avanto; Siemens Medical Solutions, Erlangen, Germany) equipped with fast gradients (45 m T/m amplitude, 200 m T/m/ms slew rate) and a phased array cardiac surface coil placed on the chest. All images were acquired with breath holding. The CMR examination began with the acquisition of survey images in 3 orthogonal planes to localize the heart within the chest. Retrospective electrocardiographic gating cine images were acquired in 3 longaxis views (ie, LV 2-chamber and 4-chamber long-axis and LVOT) and a contiguous set of short-axis sections encompassing the entire LV using generalized auto-calibrating partially parallel acquisitions (repetition time/echo time=45.9/1.07 ms, slice thickness=6 mm, matrix=109×192, field of view=350 mm, flip angle=80°) or timeadaptive sensitivity encoding (repetition time/echo time=41.7/1.39 ms, slice thickness=6 mm, matrix=109×192, field of view=350 mm, flip angle=70°) with true fast imaging with steady-state precession cine sequences. The aforementioned sequence has been previously reported. [17] [18] [19] 
CMR Analysis
All CMR images were transferred to a dedicated workstation (Siemens Medical Systems) and independently analyzed by 2 experienced observers blinded to the clinical history. For quantitative variables, a mean value from 2 readers was calculated for the analysis. The LV was divided into 6 basal, 6 midcavity, 4 distal segments, and the apex as defined by the American Heart Association/ American College of Cardiology 17-segment model. 20 Segments 1 to 16 were measured from the short-axis cine images, and the 17th segment wall thickness was measured from the long-axis cine images (Figure 1) . 20 LV mass, LV end-diastolic volume index, LV
WHAT IS KNOWN
• The presence of dynamic left ventricular outflow obstruction is associated with major adverse cardiac events in patients with hypertrophic obstructive cardiomyopathy.
• Surgical septal myectomy and alcohol septal ablation are potential treatments for hypertrophic obstructive cardiomyopathy.
• The 2011 American College of Cardiology/American
Heart Association guidelines have a recommendation of class IIb for septal alcohol ablation in those with a maximal septal thickness of ≤30 mm.
WHAT THE STUDY ADDS
• This is the first study to demonstrate that septal ablation is unlikely to be successful in patients with marked septal hypertrophy.
• We suggest that the basal anteroseptal segment <24.3 mm or the total thickness of basal anteroseptal segment and basal anterior segment <50.9 mm be an appropriate cutoff value for septal ablation.
end-systolic volume index, LV ejection fraction, stroke volume, cardiac output, and cardiac index were obtained using Argus analytic software (version VE36A).
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Inter-and intraobserver variability were tested in a subgroup of 30 subjects where 1 observer measured thickness of segment 2 once, and a second observer measured segmental thickness blinded to other results at 2 time points at least 1 weeks apart.
Statistical Analysis
Continuous variables are summarized as the mean±SD, and discrete variables are expressed as counts (percentage). Clinical and CMR characteristics were compared using a Student t test for continuous variables and Mann-Whitney U test or Fisher exact test for noncontinuous variables in 2 groups. The correlation between the 17-segment wall thickness measured by CMR and outcome of ASA was analyzed with simple linear regression analysis. Receiver operating curve (ROC) was used to identify the prediction values of CMR and echocardiography-related variables. A 2-tailed P<0.05 was considered statistically different. Statistical analysis was performed using the SPSS software package (SPSS 16.0; SPSS, Inc, Chicago, IL).
Results
Patients and Clinical Characteristics
All 102 patients underwent clinical and echocardiographic follow-up, and none were dead at 6-month follow-up (Figure 2 ). Demographic and clinical baseline characteristics are shown in Table 1 . Most of the patients (98%) were in New York Heart Association functional class III or IV despite optimal medical therapies: β-blockers in 56 patients (55%) and calcium channel blockers in 22 (22%). Dyspnea (87; 85%), angina (45; 44%), and presyncope or syncope (36; 35%) were the common symptoms in this cohort. There were no significant differences in medication or symptoms between the responding and nonresponding groups. The average amount of ethanol injected during the ablation was 2.29±0.70 mL (2.25±0.72 mL in responding group and 2.41±0.66 mL in nonresponding group; P=0.303). Peak postprocedural creatine kinase, creatine kinase-MB, and lactic dehydrogenase were 1112.53±776.60, 130.01±68.23, and 498.61±195.83 IU/L, respectively.
Six months post ASA procedure, the New York Heart Association functional class in the responding group was significantly improved (P<0.001). Thirty-seven percent of the patients (38/102) developed right bundle brunch block, and 3 patients (3%) obtained permanent pacemakers after ASA because of III AV block.
Echocardiography
LV Wall Thickness
Before ASA, the mean basal septal thicknesses for the ASA responding group, ASA nonresponding group, and entire group were 22.6±3.8, 28.2±5.5, and 24.2±5.0 mm (P<0.001), respectively. The thicknesses of the LV posterior wall for the ASA responding group, ASA nonresponding group, and entire group were 9.1±1.9, 11.4±2.4, and 9.7±2.3 mm (P<0.001), respectively. 
LVOT Pressure Gradient at 6-Month Follow-Up
The total cohort showed reduction of LVOT gradient from 84.9±32.1 to 28.2±18.8 mm Hg. We defined that reduction in LVOT gradient ≥50% of baseline as ASA responding group, and reduction in LVOT gradient <50% of baseline as ASA nonresponding group. According to this definition, 73 patients got satisfactory treatment effect 6 months post ASA procedure(ASA responding group; Figure 3 ), whereas 29 patients did not (ASA nonresponding group; Figure 4 ).There was no significant difference in LVOT pressure gradient between the 2 groups either by Doppler or catheterization during the ASA procedure ( Table 2 ). The residual LVOT gradient in the ASA responding group was 19.5±13.2 mm Hg versus 50.2±10.9 mm Hg in the ASA nonresponding group (P<0.001). The absolute LVOT For outcomes prediction, the area under the ROC curve was 0.792 (95% confidence interval, 0.698-0.886) in basal anteroseptal segment wall. A cutoff thickness of 22.6 mm yielded a sensitivity of 90% and specificity of 51% for detection of ASA nonresponder.
Cardiovascular Magnetic Resonance Imaging
The LV global function is presented in Table 3 . No significant differences were detected in LV ejection fraction, LV end-systolic volume index, LV end-diastolic volume index, SV, cardiac output, and LV mass between the 2 groups before ASA procedures (P>0.05).The correlation coefficients of the pre-ASA LV 17-segment ventricular wall thickness and the changes of LVOT gradient post procedure are summarized in Table 4 . Both the residual and the reduction rate of LVOT gradient correlated well with the basal anterior segment wall thickness ( Figure 5A and 5B), and with the basal anteroseptal segment wall thickness (Figure 5C and 5D) . Furthermore, the residual and reduction percent of LVOT gradient correlated even better with the total thickness of segment 1+2 (Figure 5E and 5F; Table 5 ).
For outcome prediction analysis, the ROC curves were 0.68 (95% confidence interval, 0.57-0.79) in segment 1, 0.79 (95% confidence interval, 0.70-0.88) in segment 2, and 0.89 (95% confidence interval, 0.83-0.95) in segment 1+2, respectively. The cutoff thicknesses of 22.0 mm (segment 1) yielded a sensitivity of 63% and a specificity of 39%. And the cutoff thickness of 24.3 mm (segment 2) yielded a sensitivity of 86% and specificity of 55%. However, a cutoff of the total thickness of segment 1+2 of 50.9 mm yielded a sensitivity of 86% and specificity of 77% for detection of ASA nonresponder ( Figure 6 ).
Intra-and Interobserver Variability
Bland-Altman analysis for intraobserver reproducibility for the thickness of segment 2 in randomly selected subgroup showed bias of 0.1±0.5 mm, with 95% limits of agreement −0.8 to 1.0 mm. Bland-Altman interobserver analysis showed a bias of 0.1±0.9 mm, with 95% confidence limits −1.1 to 0.9 mm (Figure 7 ).
Discussion
There is currently a huge unmet need for a better algorithm for predicting ASA outcome clinically.
4,7,9,11,12,21-24 ASA is given a class IIb recommendation in the 2011 American College ; however, the latest 2014 ESC guidelines stated that this recommendation was still systematic data are lacking to support. 6 To our knowledge this is the first study to provide evidence to support the anecdotal impression that the success rate of septal ablation is lower in patients with marked septal hypertrophy.
According to the results of this present study, both echocardiography and CMR evaluation revealed an inverse correlation between the thickness of basal septal thickness and the treatment effect of ASA. It showed that only 71.6% patients got satisfactory reduction of LVOT gradient 6 months after ASA is by using currently accepted criteria. Therefore, 30 mm may be a little bit too thick for basal septum recommended by the existing guidelines, and we found 25 mm would be a more appropriate cutoff value.
In view of morphological and functional model of HOCM, the LV anterior basal segment (segment 1) and basal septal segment (segment 2) form the LVOT. Therefore, theoretically, the thickness of segment 1+2 may be more relevant to LVOT gradient than other segments or the global LV mass. However, because of poor acoustic windows, echocardiography maybe weak at assessment of LV hypertrophy, particularly to assess the basal anterior, basal anterolateral, and apical segments. 25, 26 It may underestimate the severity of hypertrophy in the basal anterior wall. The cutoff thickness of anterior wall has not been currently well defined by echocardiography. CMR provides high-resolution cine-images of cardiac anatomy and the patterns of ventricular hypertrophy. [25] [26] [27] [28] [29] [30] CMR enables us to measure the basal anterior segment of LV more accurately than echo does in patients with HOCM. The present study indicated a cutoff thickness 1+2 indicates the total thickness of segment 1 and segment 2; BASW, basal anteroseptal wall thickness; CMR, cardiovascular magnetic resonance imaging; and PW, posterior wall thickness. of 22.0 mm (segment 1) yielded a sensitivity of 63% and a specificity of 39% by CMR.
For those patients who did not achieve satisfactory treatment outcomes from ASA although the target blood vessels were suitable, we found not only the basal anteroseptal segment but also the basal anterior segment was involved or even thicker. Our data demonstrated that a simple and easy evaluation by using CMR, the total thickness of segment 1+2, was a A cutoff of 50.9 mm yielded the highest sensitivity and specificity of 86% and 77%, respectively. To our knowledge, this is the first description of such a method to predict outflow tract hemodynamic in HOCM. According to previous publications, 4, 9, 13, 22, 31 factors that can influence the reduction of LVOT gradient after ASA include differences in septal coronary anatomy, position of the inflated balloon within the target artery during ethanol infusion and the ethanol volume administered. From the current study, the thickness of basal anterior segment is also an important predictor of ASA. We suggest that 7 If the thickness of the basal anteroseptal segment is >25 mm, then the thickness of basalanterior segment should be <22 mm to predict good procedure outcome. Otherwise, patients may not benefit from the procedure and need a repeated ASA or surgical septal myectomy. 32 The 3 major pathogenetic mechanisms of HOCM should be noticed: (1) hypertrophy of the anterior septum and the anterior free wall, (2) contraction and pathology of valvular, and (3) chordal apparatus of the mitral valve. 7, 24, 27 Previous publications provided evidence on the efficacy of an unfavorable anatomy, the distance from the origin of the anterior descending artery to the ablated septal branch ≥19 mm, was associated with an unsuccessful outcome. 23 The basal segment of LV anterior wall and the anterior septal wall are the most commonly hypertrophied segments. 21, 23, 25, 27, 33, 34 Our study aims to meet the need for a deeper understanding of patient selection for the septal ablation. The predictors we found may be the most effective and is consistent with anatomic structure formation of LVOT. Echocardiography remains a key modality for screening and guiding treatment in HOCM. In this study, we compared CMR and echocardiography in predicting the outcome of ASA, the total thickness of segment 1+2 assessed by CMR was better than the traditional parameterbasal anteroseptal wall thickness assessed by echocardiography ( Figure 5 ) according to the ROC analysis.
Finally, in contrast to previous studies, we took the thickness of basal anterior segment into consideration, which can be accurately measured by CMR. This information when combined with the basal anteroseptal thickness may be the best morphological parameter to predict outcomes of ASA. A CMR study before ASA with this added information may 
Limitations
As a well-studied genetic cardiomyopathy disease, the outcome of HOCM was determined by many factors, including genetic characteristics, environment factors, background medication therapy, the duration of the disease, and so forth. CMR data aids prediction, but whether it is the optimal predictor remains to be determined. Also, the retrospective, singlecenter, nonrandomized nature of the present investigation has well-known limitations, including significant potential for selection bias. We did not have internal or external validation samples, and we did not adjust for multiple testing. The sample size was relatively small, and the follow-up was a little bit short. Therefore, a larger scale and well-designed prospective study is needed to confirm our initial observations.
Conclusions
There is an inverse correlation between the thickness of basal septal wall and the outcomes of ASA. Both echocardiography and CMR can be used effectively as noninvasive tool for patient selection for ASA procedure. Comprehensive consideration of the total thickness of segments basal anterior and anteroseptal may provide more predictive value of ASA, compared with considering basal anterior segment and basal anteroseptal segment alone. A cutoff thickness of 24.3 mm for basal anteroseptal segment or a cutoff thickness of >50.9 mm for total thickness of segments basal anterior and anteroseptal may help distinguish nonresponders in those eligible for ASA. In time, this may become part of the standard workup and be provided to patients during consent.
